Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation

被引:20
作者
Bounacer, A
Wicker, R
Schlumberger, M
Sarasin, A
Suárez, HG
机构
[1] Inst Rech Sci Canc, CNRS IFC 1, Lab Genet Mol UPR 42, F-94801 Villejuif, France
[2] Inst Gustave Roussy, F-94805 Villejuif, France
关键词
radiation-associated thyroid tumors; ret proto-oncogene; activating rearrangements; RET/PTC oncogene;
D O I
10.1016/S0300-9084(97)82012-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A high frequency (approximate to 60%) of ret rearrangements in Chernobyl papillary thyroid carcinomas (PTC) has been reported recently. The data suggested that the radiation exposure may be a direct inducer of activating rearrangements in the rct gene. In our study, we have analyzed for the presence of RET/PTC oncogenes using the RT-PCR, XL-PCR. Southern blot and direct sequencing techniques, 39 human thyroid tumors from patients who had received external radiation for benign or malignant conditions. As controls, we studied 39 'spontaneous' tumors. Our results indicate that: 1) the overall frequency of ret rearrangements was 84% in papillary carcinomas (16/19) and 45% (9/20) in follicular adenomas; 2) in contrast with the results obtained in the Chernobyl tumors, the most frequently observed chimeric gene was RET/PTC1; and 3) all the tumors were negative for RET/PTC2. In the 'spontaneous' tumors, only the papillary carcinomas presented a ret rearrangement (15%: 3/20). Our data confirm the crucial role played by the ret proto-oncogene activating rearrangements in the development of radiation-associated thyroid tumors, and show, for the first time, the presence of RET/PTC genes in follicular adenomas appeared after external irradiation.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 24 条
[11]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563
[12]  
ISHIZAKA Y, 1991, ONCOGENE, V6, P1667
[13]  
ITO T, 1994, LANCET, V344, P259
[14]   THYROID-CANCER AFTER CHERNOBYL [J].
KAZAKOV, VS ;
DEMIDCHIK, EP ;
ASTAKHOVA, LN .
NATURE, 1992, 359 (6390) :21-21
[15]  
Klugbauer S, 1995, ONCOGENE, V11, P2459
[16]   ONCOGENES AND ANTIONCOGENES IN HUMAN EPITHELIAL THYROID-TUMORS [J].
SAID, S ;
SCHLUMBERGER, M ;
SUAREZ, HG .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (05) :371-379
[17]  
SANTORO M, 1994, ONCOGENE, V9, P509
[18]  
SHORE RE, 1985, J NATL CANCER I, V74, P1177
[19]   BREAKPOINT CHARACTERIZATION OF THE RET/PTC ONCOGENE IN HUMAN PAPILLARY THYROID-CARCINOMA [J].
SMANIK, PA ;
FURMINGER, TL ;
MAZZAFERRI, EL ;
JHIANG, SM .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2313-2318
[20]  
SUAREZ HG, 1991, ONCOGENE, V6, P677